Skip to main content
House subpanel weighs bills on medical product communication
7/14/2017

The House Energy and Commerce Health Subcommittee held a hearing on draft bills that would provide clarification on the information that can be included by medical device and drug makers in pre-FDA approval product communication and govern the discussion of off-label use. Subcommittee Chairman Rep. Michael Burgess, R-Texas, said the measures would provide "a targeted approach to addressing the problems presented by our outdated regulatory framework for medical product communication."

Full Story: